Beam Therapeutics Inc. Research And Development Expense

• Beam Therapeutics Inc. showed an increase of +11.4% in Research And Development Expense from 2024 to 2025.
• This data is from Beam Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), Beam Therapeutics Inc.'s Research And Development Expense has grown by 650.0%.
• Historical annual values: Fiscal year 2025: $409.62 million | Fiscal year 2024: $367.56 million | Fiscal year 2023: $437.38 million | Fiscal year 2022: $311.59 million | Fiscal year 2021: $387.09 million | Fiscal year 2020: $103.18 million | Fiscal year 2019: $54.62 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026